cefpodoxime proxetil + clavulanic acid

Cixpod-CV is a fixed-dose combination antibiotic containing cefpodoxime proxetil, a third-generation cephalosporin, and potassium clavulanate, a beta-lactamase inhibitor. Cefpodoxime proxetil acts as a prodrug that is hydrolyzed to its active form, cefpodoxime, which inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs). Clavulanic acid is included to irreversibly inhibit beta-lactamase enzymes produced by resistant bacteria, thereby protecting cefpodoxime from enzymatic degradation and extending its spectrum of activity. This combination is primarily used for the treatment of various bacterial infections, including respiratory tract infections, urinary tract infections, and skin and soft tissue infections. It is marketed as a branded generic formulation by companies such as Bengal Biopharma in the Indian pharmaceutical market.

Brand names

Cixpod-CV

Other names

Cefpodoxime Proxetil and Potassium Clavulanate Tablets